ARCHIVES

Highlights of NCDDGs: 3 Drugs on Market, 12 in Development; Advisors Approve Plan to Issue $10.5 Million Contract For Pediatric Preclinical Testing Program

This article is from The Cancer Letter archive.

Vol. 28 No. 44 | November 29, 2002

Download PDF Visit The Full Archive

Related Articles

Surveillance Following Surgery Sufficient in Stage I Seminoma

May 31, 2013

Meharry, Vanderbilt Win Grant For Research Collaboration.

March 30, 2001

House-Senate conferees Decide On $733.5 Million (Plus Training Funds) For NCI In 1976

October 31, 1975

Chemoprevention Concept Approved By DCPC Bard Uses Biological Markers To Assess Risk Modulation

September 27, 1985

STAR Begins: Critics of Trial Call For Including A Placebo Arm

June 4, 1999

In Brief: AACR Voted On Naming Delegates To Congress, Not On Attending; ACCC Membership Over 300

February 17, 1978